The Director Women’s Health Care (WHC) Research Medical Affairs serves as the WHC Research Strategy Lead for the entire WHC portfolio and is responsible for the creation & execution of the strategic & tactical goals for the portfolio with regards to market access, therapeutic area, disease state, integrated delivery, health economics and outcomes, and real-world evidence research. The incumbent develops and regularly updates Data Generation and Observational Studies (DGOS) research plans for the product/s or therapeutic area/s. The incumbent also creates and oversees the execution of tactical projects over the course of the year. The incumbent develops annual research strategy/plan for the specific product/s or therapeutic area/s in collaboration with US and Global Medical Affairs, Market Access, Global IEG, and Commercial Business Units.

YOUR TASKS AND RESPONSIBILITIES

With minimum supervision, the Director WHC Research Medical Affairs, is accountable for overall research strategy, plan, and budget for one of more products or therapeutic areas.

• Represents Data Generation and Observational Studies (DGOS) in all relevant US commercial and medical as well as the Global teams;
• As project leader, with minimum supervisory support, coordinates the activities and functions in company-wide project team/s;
• Establishes project priorities to meet all deadlines and identifies and helps his/her supervisor resolve conflicts with other projects;
• Serves as principal contact to commercial, medical and policy teams with respect to all issues of health economics and outcomes study design, execution, analysis, reporting, and interpretation;
• Is responsible and accountable for annual research plan, budget management, study execution and management, protocol approval, data accuracy, and dissemination of study results;
• Works closely with internal and external stakeholders to ensure the publication, communication, and use of results of all research projects;
• Consults with experts and investigators to ensure that state-of-the- art methods are introduced and employed within the DGOS department;
• Serves as the primacy contact/researcher and manages DGOS external strategic research collaboration projects;
• Closely monitors external policy environment and health technology assessment (HTA) requirements, e.g., the Institute for Clinical and Economic Review (ICER), to support Bayer research programs and value communication strategy;
• Incumbent must apply analytic and theoretic expertise to solve unique real-life problems of health economic and outcomes studies;
• Incumbent must have solid understanding of the U.S. healthcare system and be able to apply the knowledge in supporting DGOS research plan and commercial strategy;
• Legal and Regulatory: ensure compliance with internal and external guidelines and regulations;
• Coordinate the cross-functional launch plans for WHC;
• Oversee cross-functional teams required to achieve key research initiatives. Define and clarify initiatives, set objectives and manages the team, timelines and resources needed;
• Support development of the US WHC research;
• Support development of research strategy to address HCP, payor, and IDN segments (Primary Care and Specialty Care).

WHO YOU ARE

Bayer seeks an incumbent who possesses the following:

Required Qualifications:

• PharmD, MS, PhD or other equivalent degree in health economics, outcomes research, epidemiology, economics, or related healthcare field;
• Good written and oral presentation skills and a self- starter with the ability to maintain high productivity;
• Experience in or closely working with the pharma industry;
• Experience working in health economics and outcomes research and/or real world evidence or related field of research;
• Have ability, with minimum supervision, to design and implement research plan and programs in alignment with commercial strategy;
• Ability to travel a minimum of 10-25% of the time;
• Ability to work independently and establish priorities to ensure alignment within for research projects to meet objectives and deadlines;
• Ability to successfully lead cross-functional teams with members from US and/or global function areas;
• Ability to select and implement scientifically valid study design and methods, and interpret, explain, report, and effectively communicate the results of these studies;
• Utilize a high level of communication skills;
• Ability to represent the company at regulatory meetings including the FDA or health technology assessment (HTA) agency meetings including ICER.;
• Be accountable for the initiation, development, supervision, accuracy, appropriateness, and timely completion of all studies;
• Ability to serve as the primary contact for Research external strategy research collaborations with academic centers, payers and/or integrated delivery networks (IDNs).

Preferred Qualifications:

• At least two years’ experience in or closely working with the pharma industry;
• At least four years’ experience in health economics and outcomes research and/or real-world evidence or related field of research.

Employees can expect to be paid a salary of between $ 180,400 to $270,600. Additional compensation may include a bonus or commission (if relevant). Additional benefits include health care, vision, dental, retirement, PTO, sick leave, etc.. This salary range is merely an estimate and may vary based on an applicant’s location, market data/ranges, an applicant’s skills and prior relevant experience, certain degrees and certifications, and other relevant factors.

This posting will be available for application until at least: 2/5/2026.